Skip to main content
Equibles

Candriam S.C.A.

Position in RAPP — Rapport Therapeutics, Inc.

CIK 1537014 STRASSEN, N4
Back to RAPP Full portfolio

Position in RAPP

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$14,486,575
+$8,668,982 QoQ
Shares Held
347,650
+87.0% QoQ
Ownership
0.725%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#26
of 159 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in RAPP Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Candriam S.C.A. holds $2,107,868,027 across 75 Biotechnology names. RAPP ranks #47 (0.7% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 REGN
Regeneron Pharmaceuticals, Inc.
 195,674 $122,010,565
2 RVMD
Revolution Medicines, Inc.
 556,392 $104,201,093
3 VRTX
Vertex Pharmaceuticals Inc / Ma
 199,505 $99,100,118
4 ALNY
Alnylam Pharmaceuticals, Inc.
 314,512 $94,677,547
5 ONC
BeOne Medicines Ltd.
 289,735 $82,565,782
6 COGT
Cogent Biosciences, Inc.
 2,088,369 $80,819,880
7 ARGX
Argenx SE
 80,120 $74,332,932
8 ROIV
Roivant Sciences Ltd.
 1,990,510 $70,444,148

All Filings in RAPP

Export CSV
2 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $14,486,575 347,650
2026-03-31 $5,817,593 185,925